Cumulative evidence shows that GLP-1 exerts direct and beneficial effects on hepatocytes to protect against the progression of NAFL to NASH, suggesting that GLP-1 could be a novel therapy for NASH 14,15,16,17
The differences are in the details
Several genes that have been pointed out as oncogenes in breast cancer were shown to be downregulated in UBIAD1 OE cells, i.e., LAMA5, IL6R, SRC, CHUK/IKK, ITGA6 , and LPAR1 41,42,43,44,45,46 , and likely oncosuppressor genes were upregulated, i.e., CST3 and TINAGL1 47,48 (Fig
Application should be so light that it just
What to Do If You Experience Depression on GLP-1 If depressive symptoms emerge during GLP-1 therapy, do not stop medication abruptly
Noteworthy, each of these models has a particular target, and they are properly oriented as suited models, i.e., Parkinsons disease (MPTP, reserpine) [69], catalepsy (neuroleptics) [68,70], and schizophrenia (positive symptoms) (amphetamine) [70,152]